Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population

JOURNAL ARTICLE published October 2017 in Cancer Letters

Research funded by National High Technology Research and Development Program of China (2015AA020405) | Key Program of the National Natural Science Foundation of China (91442115) | National Natural Science Foundation of China (81672337) | Zhejiang Provincial Key Innovation Team of Pancreatic Cancer Diagnosis & Treatment (2013TD06) | Key Program of the National Natural Science Foundation of China (81530079) | Key Research and Development Project of Zhejiang Province (2015C03044)

Authors: Xiang Li | Tao Ma | Qi Zhang | Yi-Gang Chen | Cheng-Xiang Guo | Yi-Nan Shen | Pei-Wei Sun | Guo-Gang Li | Shun-Liang Gao | Ri-Sheng Que | Jian-Ying Lou | Ri-Sheng Yu | Ying Yuan | Qi-Chun Wei | Shu-Mei Wei | Yun Zhang | Lei Zheng | Xue-Li Bai | Ting-Bo Liang